Civica Rx’s Post

🤔 Did you know? Despite a decade-long discussion around on-body Large Volume Injectors (LVI), very few devices have reached the hands of patients.   In this keynote discussion at Pharmapack Europe 2024, CDP’s Head of Drug Delivery, Clare Beddoes and Deputy Head of Drug Delivery, Steve Augustyn will address the need to accelerate development and time to market, as they answers the following: 🎯 What barriers have on-body devices have faced in coming to market?  🎯 What competition do large-volume auto-injectors and ambulatory infusion pumps present?  🎯 What does the landscape look like for relevant drug product pipelines, regulations and standards? 🎯 What are the future drivers for successful LVI development? Connect with Clare, Steve and the team at Cambridge Design Partnership, or find us on Booth J52 to learn more ➡️ https://lnkd.in/ea2FkEDS #drugdelivery #pharmapack #onbody #largevolumeinjectors #timetomarket

Dress Code for Syringes sounds interesting for you? --> Then feel free to register to this webinar - experts from the industry (SCHOTT Pharma, Butler University College of Pharmacy & Health Sciences, Körber Pharma, Schreiner MediPharm) will give insight in brand new design approaches for secure and sustainable syringe supply... The webinar is free of charge but certainly with lots of value... :-) Make sure you are registered, link below... #sustainability #pharma #syringes #patientsafety

Earn FREE CE with this LIVE Webinar from ARL Bio Pharma: USP 795 Updates and Cultivating a Culture of Quality within Your Team! Register here: https://ow.ly/6qpJ50QMCjH This webinar will feature Emily Durham, MS, CPhT of Revelation Pharma and will cover approaches for educating both healthcare providers and the public on these updates, ensuring widespread understanding of the importance of these changes. #pharmacy

The New York Times just dropped a revealing video on how legacy PBMs are inflating drug costs. At SmithRx, we're writing a different story. One of the distressing examples of PBMs prioritizing profits over patient savings is with a popular autoimmune drug. In contrast, our Autoimmune Connect 360 program: - Has saved employers over $9.5M by transitioning members to affordable biosimilars like YUSIMRY - Ensures members access needed medications with minimal to no co-payment - Continuously adapts to health trends, blending care with cost-efficiency While legacy PBMs might be part of the problem, SmithRx is building the solution. We're redefining prescription drug savings with innovative programs that significantly lower medication costs for groups. Connect 360 strikes the perfect balance between financial savings and member health. Ready to learn how we can help your organization? www.smithrx.com/solutions Watch the NYT video here: https://lnkd.in/eia5VpcE

Thoughts on this? >> How to fast track approval and reimbursement of innovative medicines >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #healthcare #pharmaceutical #biotech

It's great to see how much Otrexup has grown over the years! Starting with around 4,739 units in Q4 2014 and reaching over 10,000 units by Q3 2020 is impressive. From the chart, we can see a steady increase, despite a few ups and downs, which means there's strong demand for Otrexup. Now, with an annual run rate of 42,000 units, it's clear that Otrexup has a solid place in the market. Antares Pharma has done a fantastic job making this medication available to more people. It's good to know that more patients are getting the treatment they need. #PharmaSuccess #OtrexupGrowth #HealthcareInnovation

Latest insights from James West who leads our #lifesciences efforts. Well worth reading for those looking at this sector.

In partnership with Körber Pharma and Ypsomed AG Selfcare Solutions, we invite you to join us on 18th June 2024 at our free knowledge-sharing seminar in Basel, Switzerland, for insightful discussions around the key considerations and critical success factors of your injectable products’ lifecycle.    Driven by considerations of time, cost, and internal resource limitations, sponsor companies often prioritize the immediate task at hand and achieving the next tangible milestone.     Hear from Jerome Detreille, he will guide you through future considerations at each clinical phase to assist strategic planning to pave the way for long-term success, and you will learn: • The steps you need to prepare for in advance of progressing to the next clinical phase to accelerate timelines • Phase appropriate sterile drug product processing and analytical validation • Strategies for delivering positive patient health outcomes • The key elements of a commercial readiness checklist     Seminar details and full agenda: https://lnkd.in/eae9YN5j   #CDMO #BioTech #PatientCentricity   #LetsTalkFuture

Thoughts on this? >> How to fast track approval and reimbursement of innovative medicines >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharmaceutical #pharma #healthcare

➡Black patients are 25% less likely to be discharged from the hospital on a direct-acting oral anticoagulant for atrial fibrillation than white patients3  ➡Women face a 20% higher chance of developing heart failure or dying within five years of their first heart attack than men ➡ Hispanic patients are 50% more likely to die from diabetes than white patients How can pharmaceutical companies play a crucial role in advancing health equity? Read the full article, by Dr Tim Ringrose, CEO and Founder of Cognitant here. 👉 https://lnkd.in/ekH8qiNS #healthinequalities #healthequity #healthequitynow #pharmainnovation